KYTX · Forms 3, 4, 5
Insider trades at Kyverna Therapeutics, Inc.
No open-market insider buys or sells at Kyverna Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Kyverna Therapeutics, Inc. (KYTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Kyverna Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ian T Clark | Director | Award | 5,093 | Form 4 | |||
| Fred E Cohen | Director | Award | 5,093 | Form 4 | |||
| Beth C Seidenberg | Director | Award | 5,093 | Form 4 | |||
| Christi Shaw | Executive Chairperson | Tax withholding | 4,194 | $8.59 | $36K | Form 4 | |
| Mert Aktar | Director | Award | 5,093 | Form 4 | |||
| Gregory S. Martini | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Gregory S. Martini | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Nadia Dac | Chief Commercial Officer | Options or other derivatives | Form 4 | ||||
| Nadia Dac | Chief Commercial Officer | Became an insider (Form 3) | Form 3 | ||||
| Marc Grasso | Chief Financial Officer | Award | 10,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.